Biotech News
Xtant Medical Reports Third Quarter 2025 Financial Results
investor.xtantmedical.com2026-05-06 15:10 EST
Total Revenue of $33.3 Million Increased 19% Year-over-Year Delivers Positive Net Income, Adjusted EBITDA and Operating Cash Flow Reiterates FY25 Revenue Guidance of $131-$135 Million , Representing Growth of 11%-15% over FY24 Previously Announced Sale of Certain Hardware Assets and OUS